title: Cystoid macular edema induced by nab-paclitaxel.
abstract: Cystoid macular edema (CME) is a rare complication of taxane-based chemotherapy. We encountered a patient who developed CME during treatment with nab-paclitaxel for metastatic breast cancer. Early detection of this disease enables continuation of appropriate treatment without reducing the quality of life for patients with end-stage disease. Physicians should be aware of this potential adverse effect, and should make changes to the treatment of patients as soon as possible.
authors.affiliation: Department of Breast, Thyroid and Endocrine Surgery, Tsukuba University, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan, choshi_sai_yuu@k6.dion.ne.jp.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Tanaka
authors.forename: Hiroko
authors.initials: H
authors.lastname: Bando
authors.forename: Hisato
authors.initials: H
authors.lastname: Hara
authors.forename: Yasuaki
authors.initials: Y
authors.lastname: Ito
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Okamoto
mesh_terms: D000418:Albumins / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008269:Macular Edema / Q000139:chemically induced*; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects*; D011379:Prognosis; D011788:Quality of Life
chemical_list: C520255:130-nm albumin-bound paclitaxel; D000418:Albumins; D017239:Paclitaxel